These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2449)

  • 21. [The new Russian preparation proxodolol in the treatment of arterial hypertension].
    Ol'binskaia LI; Morozova TE
    Eksp Klin Farmakol; 1994; 57(3):42-5. PubMed ID: 7914119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive activity of a new vasodilator, cadralazine, administered alone or in combination with a beta-blocker.
    Buoninconti R; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):613-6. PubMed ID: 2867048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tertatolol--characteristics of the drug].
    Tomaszewski R; Kliz J
    Wiad Lek; 1992 Mar; 45(5-6):196, 200, 204 passim. PubMed ID: 1360731
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of metoprolol CR/ZOK in the cardiological practice].
    Podzolkov VI; Samoĭlenko VV; Osadchiĭ KK; Strizhakov LA
    Ter Arkh; 2000; 72(9):78-80. PubMed ID: 11076427
    [No Abstract]   [Full Text] [Related]  

  • 25. A preliminary clinical trial of Prazosin: a new oral antihypertensive agent.
    Bolli P; Simpson FO
    N Z Med J; 1974 May; 79(516):969-72. PubMed ID: 4152750
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of tolamolol versus propranolol on systolic time intervals in angina.
    Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hemodynamics of hypertension. Changes caused by beta-blocking agents].
    Mattioli G; Ricci S; Bertoncelli P
    Minerva Cardioangiol; 1979; 27(7-8):463-72. PubMed ID: 44898
    [No Abstract]   [Full Text] [Related]  

  • 29. Age and responses to isometric exercise in hypertension: possible predictors of the antihypertensive effect of diuretics and beta-blockers.
    Corea L; Valori C; Bentivoglio M; Verdecchia P; Bichisao E
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):554-9. PubMed ID: 2866164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Beta-adrenoblockers for the correction of arterial hypertension in postmenopausal women].
    Latfullin IA; Ishmurzin GP; Gaĭfullina RF; Akhmerova RI; Kim ZF; Podol'skaia AA
    Klin Med (Mosk); 2010; 88(2):68-71. PubMed ID: 21105477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The efficacy of proxodolol in patients with stable arterial hypertension].
    Metelitsa VI; Ostrovskaia TP; Duda SG; Shastun RS; Chel'dieva EIa; Simonov DV; Kalinin AL; Kekshina MS
    Eksp Klin Farmakol; 1994; 57(3):38-42. PubMed ID: 7914118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Celiprolol efficacy and tolerance in the treatment of arterial hypertension].
    Lobos Bejarano JM; Granados Menéndez MI; del Valle González J; Bravo Juega P
    An Med Interna; 1991 Jan; 8(1):52-3. PubMed ID: 1680475
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan.
    Noshiro T; Miura Y; Yoshinaga K; Iimura O; Inagaki Y; Saruta T; Ishii M; Yamazaki N; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):240-5. PubMed ID: 7620695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Celiprolol].
    Galende I; Suárez JR; Azanza JR; Honorato J
    Rev Med Univ Navarra; 1988; 32(4):229-32. PubMed ID: 2908736
    [No Abstract]   [Full Text] [Related]  

  • 36. [Field study: long-term antihypertensive therapy with the beta blocker nadolol in a once-a-day dosage - an outpatient study of Swiss medical practices].
    Bertel O; Conen D; Renggli I
    Schweiz Rundsch Med Prax; 1983 Feb; 72(8):264-8. PubMed ID: 6132374
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.
    Trimarco B; Lembo G; DeLuca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
    J Int Med Res; 1988; 16 Suppl 1():62A-72A. PubMed ID: 2906018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of clinical usefulness of beta-blocker in aged and younger essential hypertension. Double blind trial using bunitrolol].
    Kuramoto K; Ikeda M; Arakawa K; Inagaki Y; Kaneko Y; Masuyama Y; Yamazaki N; Tsuchiya M
    Nihon Ronen Igakkai Zasshi; 1984 Jan; 21(1):20-6. PubMed ID: 6145808
    [No Abstract]   [Full Text] [Related]  

  • 39. Timolol maleate (Blocadren) in the treatment of essential hypertension.
    O'Brien KP
    N Z Med J; 1975 Nov; 82(551):293-6. PubMed ID: 1695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride.
    Tarkiainen A; Saraste K; Seppälä T; Gordin A; Auvinen J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):239-44. PubMed ID: 6116605
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.